(19)
(11) EP 4 815 979 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 23960321.0

(22) Date of filing: 30.11.2023
(51) International Patent Classification (IPC): 
A61K 38/51(2006.01)
A61P 25/00(2006.01)
A61P 9/10(2006.01)
A61P 39/06(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Y 402/01092; A61K 38/51; A61P 39/06; A61K 9/0043
(86) International application number:
PCT/NZ2023/050141
(87) International publication number:
WO 2025/116747 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(71) Applicant: Lipoxagen Limited
4410 Palmerston North (NZ)

(72) Inventors:
  • MACKAY, Sean
     (NZ)
  • CLARKSON, Andrew
     (NZ)

(74) Representative: Ström & Gulliksson AB 
P.O. Box 4188
203 13 Malmö
203 13 Malmö (SE)

   


(54) TREATMENT OF CENTRAL NERVOUS SYSTEM INJURY